CDC Updates RSV Vaccine Recommendations for Adults 60+
(July 2, 2024) On June 26th, the Centers for Disease Control and Prevention (CDC) updated its recommendations for the use of Respiratory Syncytial Virus (RSV) vaccines in adults aged 60 and older for the upcoming respiratory virus season.
The new recommendations are:
- All adults aged 75 and older should receive the RSV vaccine.
- Adults aged 60-74 who are at increased risk of severe RSV due to certain chronic medical conditions (e.g., lung or heart disease) or who live in nursing homes should receive the RSV vaccine.
The updated recommendations apply to adults who did not receive an RSV vaccine last year. The RSV vaccine is not an annual vaccine, so individuals do not need a dose every RSV season. However, the best time to get vaccinated is in late summer and early fall, before RSV typically starts to spread. The updated recommendations aim to simplify RSV vaccine decision-making for clinicians and the public, replacing the previous guidance from last year. The revision is based on analyses of RSV disease burden, vaccine effectiveness, and cost-effectiveness, incorporating the first real-world data since RSV vaccines were recommended for adults aged 60 and older. According to the CDC, health care providers should advise eligible patients to receive the RSV vaccine and discuss other necessary vaccines to prevent respiratory infections this fall.
Contact: Amy Nelson, anelson@leadingageny.org, 518-867-8383 ext. 146